Treatment Strategies for the Prevention of Heart Failure

• Published in: Current heart failure reports Vol. 10; no. 4; pp. 331 - 340
• Main Authors: Grodin, Justin L., Tang, W. H. Wilson
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.12.2013
• Subjects: Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive Agents - therapeutic use; Biomarkers - blood; Cardiac Surgery; Cardiology; Coronary Disease - complications; Coronary Disease - drug therapy; Diabetes Complications - prevention & control; Heart Failure - blood; Heart Failure - etiology; Heart Failure - prevention & control; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hyperlipidemias - complications; Hyperlipidemias - drug therapy; Hypertension - complications; Hypertension - drug therapy; Imaging; Internal Medicine; Medicine; Medicine & Public Health; Phenotype; Prevention of Heart Failure (M St. John Sutton; Radiology; Risk Factors; Section Editor; Vascular Surgery; Heart failure; Hypertension; Brain natriuretic peptide; Obesity; Cardiomyopathy; Hyperlipidemia; Diabetes mellitus; Angiotensin receptor blocker; Coronary artery disease; Prevention; Troponin; Angiotensin converting enzyme inhibitor; Beta-blocker; Left ventricular hypertrophy; Biomarkers; Insulin resistance; Left bundle branch block; Thiazide diuretic; Statins

With the astounding morbidity and mortality associated with heart failure (HF), preventive approaches have been explored. Controlling hypertension to prevent HF is well-established, especially with sodium restriction and thiazide-based antihypertensive therapies showing potential advantages. Control...